Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Assessment of metabolic dysfunction-associated steatotic liver disease, alcohol-associated liver disease, and metabolic dysfunction and alcohol-associated steatotic liver disease in open Mexican population
Jorge Emilio Lira-Vera; Ángel Daniel Santana-Vargas; Gabriela Gutiérrez-Reyes; Oscar Morales-Gutiérrez; María de Fátima Higuera-de la Tijera; Diana Montemira-Orozco; Christian Hinojosa-Segura; Moisés Martínez-Castillo; Samantha Sánchez-Valle; María de los Ángeles Lemus-Peña; Daniel Montes de Oca-Ángeles; Abigail Hernández-Barragán; Marisela Hernández-Santillán; Yadira Lilian Béjar-Ramírez; José Luis Pérez-Hernández;
Ann Hepatol. 2026;31:
Association of sleep patterns and disorders with metabolic dysfunction-associated steatotic liver disease and liver fibrosis in contemporary American adults
Guannan Zong; Wangjia Mao; Ming Wen; Xiaoyun Cheng; Guanghui Liu;
10.1016/j.aohep.2024.101583
Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019
Jacob Romano; Jessica Burnside; Giada Sebastiani; Alnoor Ramji; Keyur Patel; Mark Swain; Sahar Saeed;
10.1016/j.aohep.2024.101757